Rose Ventures

Xeno Biosciences Inc. is a biopharmaceutical company based in Somerville, Massachusetts, established in 2015. It specializes in developing innovative therapeutics aimed at addressing significant unmet needs in metabolic diseases, particularly obesity. The company's lead program, XEN-101, is an oral formulation that mimics the microbiome shift associated with Roux-en-Y Gastric Bypass (RYGB) surgery, promoting weight loss. Xeno Biosciences' approach involves a simple enteric-coated pill that delivers molecular oxygen to the lower gut, enabling a treatment strategy that replicates the effects of gastric bypass surgery on the gut microbiome.

CellChorus specializes in advanced single-cell analysis for biopharmaceutical companies, utilizing its proprietary TIMING™ platform. This visual artificial intelligence technology enables dynamic evaluation of cell activation, killing, and movement over time. By integrating data on kinetics and interactions with insights from single-cell RNA sequencing and flow cytometry, CellChorus provides healthcare organizations with a comprehensive understanding of cellular function, state, and phenotype. This innovative approach aims to enhance the development and efficacy of immuno-oncology therapies and other medical treatments.

Invenra Inc. is a biotechnology company based in Madison, Wisconsin, founded in 2011. The company specializes in discovering and developing biologics, particularly antibodies and their derivatives. Invenra employs a unique drug discovery platform that integrates cell-free expression technology with extreme miniaturization, allowing for the screening of a vast number of full-length antibodies in phenotypic assays. This innovative approach enables the identification and optimization of human multi-specific antibodies for therapeutic applications, including treatments for cancer, Alzheimer's disease, and diabetes. Invenra's team consists of experienced scientists with expertise in genomics, biochemistry, and bioengineering, blending advanced research with practical applications in the development of new biologic drugs.

Nira Skin is a brand or line of skincare products. It offers products that include moisturizers, cleansers, toners, serums, and other skincare items. Nira Skin distributes its products across retail, home shopping, direct to consumer, ecommerce, and international channels.

Cellular Dynamics International Inc., (CDI) is a developer and manufacturer of fully functioning cells in industrial quantities to precise specifications. CDI's proprietary products include true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell Products). CDI's products provide standardized, easy-to-use, cost-effective access to the human cell, the smallest fully functioning operating unit of human biology. Customers use our products, among other purposes, for drug discovery and screening, to test the safety and efficacy of their small molecule and biological drug candidates, for stem cell banking, and in the research and development of cellular therapeutics.

Invenra Inc. is a biotechnology company based in Madison, Wisconsin, founded in 2011. The company specializes in discovering and developing biologics, particularly antibodies and their derivatives. Invenra employs a unique drug discovery platform that integrates cell-free expression technology with extreme miniaturization, allowing for the screening of a vast number of full-length antibodies in phenotypic assays. This innovative approach enables the identification and optimization of human multi-specific antibodies for therapeutic applications, including treatments for cancer, Alzheimer's disease, and diabetes. Invenra's team consists of experienced scientists with expertise in genomics, biochemistry, and bioengineering, blending advanced research with practical applications in the development of new biologic drugs.